Session Details
[LS-33]Luncheon Seminar 33 The Importance of Evidence-Based Anti-CD20 Therapies
Fri. May 23, 2025 12:00 PM - 1:00 PM JST
Fri. May 23, 2025 3:00 AM - 4:00 AM UTC
Fri. May 23, 2025 3:00 AM - 4:00 AM UTC
第07会場(大阪国際会議場12F 特別会議場)
Chairs: Ryotaro Ikeguchi（Tokyo Women’s Medical University, Japan）, Makoto Kinoshita（Osaka University, Japan）
Sponsored by: Novartis Pharma K.K.
[LS-33-1]Early High Efficacy Therapy and Shared Decision Making
Yuji Tomizawa (Juntendo University Faculty of Medicine, Japan)
[LS-33-2]Ofatumumab Real World Data in 535 Japanese MS Patients
Takahiko Saida (Kansai MS Center/Irino Medical Clinic, Kyoto Miniren Chuo Hospital, Japan)